MAP3K13 抗体 (AA 801-900) (HRP)
Quick Overview for MAP3K13 抗体 (AA 801-900) (HRP) (ABIN5557394)
抗原
See all MAP3K13 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 801-900
-
交叉反应
- 人, 小鼠
-
预测反应
- Cow
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human MAP3K13
-
亚型
- IgG
-
-
-
-
应用备注
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
别名
- MAP3K13
-
背景
-
Synonyms: Mitogen-activated protein kinase kinase kinase 13, MAP3K13, Leucine zipper-bearing kinase, Mixed lineage kinase, MLK, LZK
Background: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
-
基因ID
- 9175
-
UniProt
- O43283
-
途径
- Signaling Events mediated by VEGFR1 and VEGFR2
抗原
-